ICPHCMS 2026: International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome

ICPHCMS 2026: International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome addresses the identification, risk assessment, and therapeutic management of early-stage cardiovascular risk factors, focusing on the physiological impacts and clinical progression of prehypertension, prediabetes, and metabolic syndrome across diverse patient populations.

Key Topics

• Prediabetes – Mechanisms, Diagnosis and Management
• Metabolic Syndrome and Vitamin D
• Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
• Pre-Levels of CV Risk Factors – Boosting Risk of Events and Deciding Who Should be Treated
• Total Cardiovascular Risk Evaluation and Management
• PreHypertension and Metabolic Syndrome in Different Populations – Epidemiologic Aspects
• Cardiac Markers of Pre-Clinical Disease in Metabolic Syndrome Patients
• Arterial Properties, Evaluation and Treatment in Metabolic Syndrome
• Which Elderly Patients with Pre-Disease should be Considered for Medical Treatment
• Effect of Pre-Disease Risk Factors in Patients with the Metabolic Syndrome on Morbidity and Mortality
• The Heart, the Brain and the Kidney in Pre-Disease and the Metabolic Syndrome
• Children and Adolescents: PreHypertension and Metabolic Syndrome, Progression of Risk and Diagnosis of Disease
• Arterial Properties, Central Blood Pressure and Augmentation Index in Pre-Disease and Disease in Patients with Cardiometabolic Syndrome
• Addressing the Global CV Risk Factors in Pre-Disease and in Disease
• PreHypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
• PreHypertension, Hypertension and Renal Denervation
• Gestational Prehypertension and Gestational Hypertension
• Cardiometabolic Syndrome in Children